[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Pituitary cancer Market Report (Status and Outlook)

August 2018 | 130 pages | ID: 275F1450A81EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Pituitary cancer market for 2018-2023.

Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.
Over the next five years, LPI(LP Information) projects that Pituitary cancer will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Pituitary cancer market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • Blood Tests
  • Urine Test
  • Vision Testing
Segmentation by application:
  • Hospital
  • Clinics
  • Diagnostic Centers
  • Research Institutes
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • Trinity Biotech
  • Salzman
  • Genentech
  • Sigma-Aldrich
  • Varian Medical Systems
  • Elekta
  • Accuray Incorporated
  • Ion Beam Applications
  • Nordion
  • C. R. Bard
  • Isoray Medical
  • RaySearch Laboratories
  • Mevion Medical Systems
  • Mitsubishi Electric
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Pituitary cancer market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Pituitary cancer market by identifying its various subsegments.
  • Focuses on the key global Pituitary cancer players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Pituitary cancer with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Pituitary cancer submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pituitary cancer Market Size 2013-2023
  2.1.2 Pituitary cancer Market Size CAGR by Region
2.2 Pituitary cancer Segment by Type
  2.2.1 Blood Tests
  2.2.2 Urine Test
  2.2.3 Brain Imaging
  2.2.4 Vision Testing
2.3 Pituitary cancer Market Size by Type
  2.3.1 Global Pituitary cancer Market Size Market Share by Type (2013-2018)
  2.3.2 Global Pituitary cancer Market Size Growth Rate by Type (2013-2018)
2.4 Pituitary cancer Segment by Application
  2.4.1 Hospital
  2.4.2 Clinics
  2.4.3 Diagnostic Centers
  2.4.4 Research Institutes
2.5 Pituitary cancer Market Size by Application
  2.5.1 Global Pituitary cancer Market Size Market Share by Application (2013-2018)
  2.5.2 Global Pituitary cancer Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PITUITARY CANCER BY PLAYERS

3.1 Global Pituitary cancer Market Size Market Share by Players
  3.1.1 Global Pituitary cancer Market Size by Players (2016-2018)
  3.1.2 Global Pituitary cancer Market Size Market Share by Players (2016-2018)
3.2 Global Pituitary cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PITUITARY CANCER BY REGIONS

4.1 Pituitary cancer Market Size by Regions
4.2 Americas Pituitary cancer Market Size Growth
4.3 APAC Pituitary cancer Market Size Growth
4.4 Europe Pituitary cancer Market Size Growth
4.5 Middle East & Africa Pituitary cancer Market Size Growth

5 AMERICAS

5.1 Americas Pituitary cancer Market Size by Countries
5.2 Americas Pituitary cancer Market Size by Type
5.3 Americas Pituitary cancer Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Pituitary cancer Market Size by Countries
6.2 APAC Pituitary cancer Market Size by Type
6.3 APAC Pituitary cancer Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Pituitary cancer by Countries
7.2 Europe Pituitary cancer Market Size by Type
7.3 Europe Pituitary cancer Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pituitary cancer by Countries
8.2 Middle East & Africa Pituitary cancer Market Size by Type
8.3 Middle East & Africa Pituitary cancer Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PITUITARY CANCER MARKET FORECAST

10.1 Global Pituitary cancer Market Size Forecast (2018-2023)
10.2 Global Pituitary cancer Forecast by Regions
  10.2.1 Global Pituitary cancer Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Pituitary cancer Forecast by Type
10.8 Global Pituitary cancer Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Trinity Biotech
  11.1.1 Company Details
  11.1.2 Pituitary cancer Product Offered
  11.1.3 Trinity Biotech Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Trinity Biotech News
11.2 Salzman
  11.2.1 Company Details
  11.2.2 Pituitary cancer Product Offered
  11.2.3 Salzman Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Salzman News
11.3 Genentech
  11.3.1 Company Details
  11.3.2 Pituitary cancer Product Offered
  11.3.3 Genentech Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Genentech News
11.4 Sigma-Aldrich
  11.4.1 Company Details
  11.4.2 Pituitary cancer Product Offered
  11.4.3 Sigma-Aldrich Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Sigma-Aldrich News
11.5 Varian Medical Systems
  11.5.1 Company Details
  11.5.2 Pituitary cancer Product Offered
  11.5.3 Varian Medical Systems Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Varian Medical Systems News
11.6 Elekta
  11.6.1 Company Details
  11.6.2 Pituitary cancer Product Offered
  11.6.3 Elekta Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Elekta News
11.7 Accuray Incorporated
  11.7.1 Company Details
  11.7.2 Pituitary cancer Product Offered
  11.7.3 Accuray Incorporated Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Accuray Incorporated News
11.8 Ion Beam Applications
  11.8.1 Company Details
  11.8.2 Pituitary cancer Product Offered
  11.8.3 Ion Beam Applications Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Ion Beam Applications News
11.9 Nordion
  11.9.1 Company Details
  11.9.2 Pituitary cancer Product Offered
  11.9.3 Nordion Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Nordion News
11.10 C. R. Bard
  11.10.1 Company Details
  11.10.2 Pituitary cancer Product Offered
  11.10.3 C. R. Bard Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 C. R. Bard News
11.11 Isoray Medical
11.12 RaySearch Laboratories
11.13 Mevion Medical Systems
11.14 Mitsubishi Electric

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of Pituitary cancer
Figure Pituitary cancer Report Years Considered
Figure Market Research Methodology
Figure Global Pituitary cancer Market Size Growth Rate 2013-202


More Publications